Medical device usability has emerged as a critical patient safety concern, with use errors contributing to 24% of device-related adverse events. Regulatory authorities have responded by establishing requirements for applying usability engineering thro...
Medical device usability has emerged as a critical patient safety concern, with use errors contributing to 24% of device-related adverse events. Regulatory authorities have responded by establishing requirements for applying usability engineering throughout medical device development. However, manufacturers face a fragmented landscape of overlapping standards and guidance documents—including ISO 13485 (quality management), ISO 14971 (risk management), IEC 62366-1 (usability engineering), IEC 62304 (software lifecycle), and FDA human factors guidance—each requiring separate documentation and compliance activities. This fragmentation forces manufacturers, particularly small-medium manufacturers with limited human factors expertise, to independently synthesize guidance, resulting in implementation variations, inefficiencies, and potential compliance gaps that may ultimately weaken the intended safety benefits. Despite numerous proposed frameworks for medical device usability engineering, most address individual standards in isolation, lack empirical validation through prospective implementation, or provide insufficient practical guidance for real-world application. A validated, comprehensive framework integrating multiple regulatory standards throughout the complete development lifecycle remains absent from literature and practice.
This research aimed to develop and validate an integrated usability engineering regulatory framework that harmonizes requirements from five international standards and regulatory guidance documents, providing manufacturers with systematic, phase-specific guidance enabling simultaneous satisfaction of multiple regulatory requirements through unified activities and documentation. The framework addresses two critical gaps: (1) lack of comprehensive integration guidance covering all relevant standards, and (2) limited empirical validation through application in actual development projects. The primary research question is following: How can usability engineering and requirements from international standards be systematically integrated into a unified framework that is complete, implementable, and effective for medical device development?
The research consists of two parts. Part 1 developed a comprehensive framework organizing usability engineering activities across the product realization lifecycle through analyzing requirements of regulatory sources (ISO 13485, ISO 14971, IEC 62366-1, IEC 62304, FDA Human Factors Guidance). The cycle includes: (1) Planning & Preparation, (2) User Research & Use Analysis, (3) Design & Formative Evaluation, (4) Design Verification, (5) Design Validation (Summative Evaluation), and (6) Design Transfer & Regulatory Submission. Each phase specifies required activities, integration points across standards, and deliverables. Supporting tools include documentation templates and decision support checklists. Part 2 validated the framework through prospective case study application in two diverse medical device development projects, assessing three pre-defined criteria: completeness, implementation success, and outcome effectiveness.
Total of 257 requirements were identified as mandatory requirements across the five standards applicable to pre-market device development, with approximately 40% overlap particularly between use specification (IEC 62366-1), intended use and hazard identification (ISO 14971), and design inputs (ISO 13485). The three uncovered requirements were related to post-market activities which are explicitly excluded from research scope. Completeness within the defined pre-market scope reached 100%, with zero documentation gaps.
The framework was applied in two case studies: (1) a continuous renal replacement therapy (CRRT) device (Class III), and (2) a neonatal incubator developed (Class III). Both projects successfully developed each medical device through completing all six framework phases, produced all required deliverables, and achieved Korea MFDS regulatory approval. The CRRT device conducted extensive user research (n=204 participants), two formative evaluation cycles identifying and resolving usability issues, and summative validation with 16 ICU nurses demonstrating 0 critical use errors, 3.3% overall use error rate, and 4.08/5.0 user satisfaction. The neonatal incubator employed focused expert interviews (n=6), four iterative formative cycles (n=6-9 per cycle) addressing physical, software, and cleaning features, and summative validation with 15 NICU nurses demonstrating 0 critical use errors, 0.14% use error rate, and 4.04/5.0 satisfaction. Both cases demonstrated integrated regulatory strategy, while achieving complete traceability from user needs through validation.
Both case studies involved MFDS Class III devices (CRRT and neonatal incubator), revealing usability characteristic of high-risk medical technologies. Common challenges included complex user interfaces requiring simultaneous monitoring of multiple physiological variables, critical care environments characterized by time pressure and high cognitive load, and alarm management complexity leading to potential alarm fatigue. These findings align with established human factors knowledge, where use-related risks carry the highest severity levels and demand rigorous systematic approaches.
This research demonstrates that comprehensive integration of usability engineering with regulatory requirements throughout medical device development is both feasible and beneficial. The validated framework addresses fragmentation in current practice by consolidating overlapping requirements from five international standards into unified workflows, achieving 58.97% requirements consolidation while maintaining complete regulatory compliance. The framework also supports iterative refinement through bidirectional pathways, enabling return to earlier phases when new risks or design changes emerge or validation criteria are not met, rather than following a linear progression.
The framework contributes to both academic understanding and practical advancement of medical device development. Academically, it provides quantitative evidence demonstrating framework effectiveness: regulatory compliance quality (0 deficiencies versus 95.1% reported deficiencies), economic efficiency (approximately 6:1 return on investment through early problem detection, resource reduction), and usability outcomes (19-36% error reduction in retrospective analysis of 81 Korean manufacturers). Practically, it offers manufacturers easy-to-follow templates and implementation guidance that can prevent common regulatory failures while reducing documentation burden.
Limitations include device type diversity (two cases: CRRT and neonatal incubator), single-country regulatory validation (Korea MFDS), and modest sample size for statistical generalization. Future research should validate framework applicability across different device categories with emerging technology (digital health, implantable devices, AI/ML-enabled systems) and broader regulatory contexts (FDA, EU MDR, Health Canada).
Medical device usability engineering stands at a critical point where regulatory expectations increasingly demand systematic approaches, yet implementation guidance remains fragmented across multiple standards. This research provides validated methodology demonstrating that integrated approaches transform regulatory compliance from administrative burden to strategic advantage, enabling simultaneous achievement of regulatory excellence, development efficiency, and enhanced patient safety.